These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 24755001)
1. Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration. Goodhew EB; Morgan SM; Switzer AJ; Munoz B; Dize L; Gaydos C; Mkocha H; West SK; Wiegand RE; Lammie PJ; Martin DL BMC Infect Dis; 2014 Apr; 14():216. PubMed ID: 24755001 [TBL] [Abstract][Full Text] [Related]
2. Serology for trachoma surveillance after cessation of mass drug administration. Martin DL; Bid R; Sandi F; Goodhew EB; Massae PA; Lasway A; Philippin H; Makupa W; Molina S; Holland MJ; Mabey DC; Drakeley C; Lammie PJ; Solomon AW PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003555. PubMed ID: 25714363 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of a Single Dose of Azithromycin for Trachoma in Low-Prevalence Communities. Wilson N; Goodhew B; Mkocha H; Joseph K; Bandea C; Black C; Igietseme J; Munoz B; West SK; Lammie P; Kasubi M; Martin DL Ophthalmic Epidemiol; 2019 Feb; 26(1):1-6. PubMed ID: 30543311 [TBL] [Abstract][Full Text] [Related]
4. The conjunctival microbiome before and after azithromycin mass drug administration for trachoma control in a cohort of Tanzanian children. Pickering H; Ramadhani AM; Massae P; Mafuru E; Malisa A; Mbuya K; Makupa W; Mtuy T; Derrick T; Houghton J; Bailey RL; Mabey DCW; Burton MJ; Holland MJ Front Public Health; 2022; 10():1015714. PubMed ID: 36324475 [TBL] [Abstract][Full Text] [Related]
5. Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal. Harding-Esch EM; Holland MJ; Schémann JF; Sillah A; Sarr B; Christerson L; Pickering H; Molina-Gonzalez S; Sarr I; Andreasen AA; Jeffries D; Grundy C; Mabey DCW; Herrmann B; Bailey RL Parasit Vectors; 2019 Oct; 12(1):497. PubMed ID: 31640755 [TBL] [Abstract][Full Text] [Related]
6. The effect of multiple rounds of mass drug administration on the association between ocular Chlamydia trachomatis infection and follicular trachoma in preschool-aged children. Lee JS; Muñoz BE; Mkocha H; Gaydos CA; Quinn TC; West SK PLoS Negl Trop Dis; 2014 Apr; 8(4):e2761. PubMed ID: 24722392 [TBL] [Abstract][Full Text] [Related]
8. Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community. Ramadhani AM; Derrick T; Macleod D; Massae P; Malisa A; Mbuya K; Mtuy T; Makupa W; Roberts CH; Bailey RL; Mabey DCW; Holland MJ; Burton MJ PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007559. PubMed ID: 31306419 [TBL] [Abstract][Full Text] [Related]
9. Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units. Burr SE; Hart J; Samikwa L; Chaima D; Cooley G; Martin D; Masika M; Solomon AW; Bailey RL; Kalua K PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007749. PubMed ID: 31658258 [TBL] [Abstract][Full Text] [Related]
10. Risk of Infection with Chlamydia trachomatis from Migrants to Communities Undergoing Mass Drug Administration for Trachoma Control. West SK; Munoz BE; Mkocha H; Gaydos C; Quinn T Ophthalmic Epidemiol; 2015; 22(3):170-5. PubMed ID: 26158574 [TBL] [Abstract][Full Text] [Related]
11. Chlamydial positivity of nasal discharge at baseline is associated with ocular chlamydial positivity 2 months following azithromycin treatment. Gower EW; Solomon AW; Burton MJ; Aguirre A; Muñoz B; Bailey R; Holland M; Makalo P; Massae P; Mkocha H; Mabey DC; West SK Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4767-71. PubMed ID: 17065486 [TBL] [Abstract][Full Text] [Related]
12. Geospatial distribution and clustering of Chlamydia trachomatis in communities undergoing mass azithromycin treatment. Yohannan J; He B; Wang J; Greene G; Schein Y; Mkocha H; Munoz B; Quinn TC; Gaydos C; West SK Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4144-50. PubMed ID: 24906862 [TBL] [Abstract][Full Text] [Related]
13. CT694 and pgp3 as serological tools for monitoring trachoma programs. Goodhew EB; Priest JW; Moss DM; Zhong G; Munoz B; Mkocha H; Martin DL; West SK; Gaydos C; Lammie PJ PLoS Negl Trop Dis; 2012; 6(11):e1873. PubMed ID: 23133684 [TBL] [Abstract][Full Text] [Related]
14. The influence of local antichlamydial antibody on the acquisition and persistence of human ocular chlamydial infection: IgG antibodies are not protective. Bailey RL; Kajbaf M; Whittle HC; Ward ME; Mabey DC Epidemiol Infect; 1993 Oct; 111(2):315-24. PubMed ID: 8405158 [TBL] [Abstract][Full Text] [Related]
15. Constant ocular infection with Chlamydia trachomatis predicts risk of scarring in children in Tanzania. Wolle MA; Muñoz BE; Mkocha H; West SK Ophthalmology; 2009 Feb; 116(2):243-7. PubMed ID: 19091415 [TBL] [Abstract][Full Text] [Related]
16. Stopping azithromycin mass drug administration for trachoma: A systematic review. Mahmud H; Landskroner E; Amza A; Aragie S; Godwin WW; de Hostos Barth A; O'Brien KS; Lietman TM; Oldenburg CE PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009491. PubMed ID: 34237074 [TBL] [Abstract][Full Text] [Related]
17. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. West SK; Munoz B; Mkocha H; Holland MJ; Aguirre A; Solomon AW; Foster A; Bailey RL; Mabey DC Lancet; 2005 Oct; 366(9493):1296-300. PubMed ID: 16214600 [TBL] [Abstract][Full Text] [Related]
18. The impact of a single round of community mass treatment with azithromycin on disease severity and ocular Chlamydia trachomatis load in treatment-naïve trachoma-endemic island communities in West Africa. Last AR; Burr SE; Harding-Esch E; Cassama E; Nabicassa M; Roberts CH; Mabey DCW; Holland MJ; Bailey RL Parasit Vectors; 2017 Dec; 10(1):624. PubMed ID: 29282126 [TBL] [Abstract][Full Text] [Related]
19. The effect of Mass Drug Administration for trachoma on antibodies to Chlamydia trachomatis pgp3 in children. West SK; Munoz B; Mkocha H; Gaydos CA; Quinn TC Sci Rep; 2020 Sep; 10(1):15225. PubMed ID: 32938957 [TBL] [Abstract][Full Text] [Related]
20. The Performance of Immunoassays to Measure Antibodies to the Chlamydia trachomatis Antigen Pgp3 in Different Epidemiological Settings for Trachoma. Gwyn S; Nute AW; Sata E; Tadesse Z; Chernet A; Haile M; Zeru T; Bethea D; Laurent C; Callahan EK; Nash SD; Martin DL Am J Trop Med Hyg; 2021 Aug; 105(5):1362-1367. PubMed ID: 34398819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]